Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Energy Level Engineering of MoS2 by Transition-Metal Doping for Accelerating Hydrogen Evolution Reaction.

Shi Y, Zhou Y, Yang DR, Xu WX, Wang C, Wang FB, Xu JJ, Xia XH, Chen HY.

J Am Chem Soc. 2017 Nov 1;139(43):15479-15485. doi: 10.1021/jacs.7b08881. Epub 2017 Oct 19.

PMID:
29032672
2.

Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.

Xu L, Chen X, Shen M, Yang DR, Fang L, Weng G, Tsai Y, Keng PC, Chen Y, Lee SO.

Mol Oncol. 2017 Sep 2. doi: 10.1002/1878-0261.12135. [Epub ahead of print]

3.

Transrectal real-time tissue elastography targeted biopsy coupled with peak strain index improves the detection of clinically important prostate cancer.

Ma Q, Yang DR, Xue BX, Wang C, Chen HB, Dong Y, Wang CS, Shan YX.

Oncol Lett. 2017 Jul;14(1):210-216. doi: 10.3892/ol.2017.6126. Epub 2017 May 5.

4.

Breviscapine (BVP) inhibits prostate cancer progression through damaging DNA by minichromosome maintenance protein-7 (MCM-7) modulation.

Guan YB, Yang DR, Nong SJ, Ni J, Hu CH, Li J, Zhu J, Shan YX.

Biomed Pharmacother. 2017 Sep;93:103-116. doi: 10.1016/j.biopha.2017.06.024. Epub 2017 Jun 17.

PMID:
28628830
5.

TR2 and TR4 Orphan Nuclear Receptors: An Overview.

Lin SJ, Yang DR, Yang G, Lin CY, Chang HC, Li G, Chang C.

Curr Top Dev Biol. 2017;125:357-373. doi: 10.1016/bs.ctdb.2017.02.002. Epub 2017 Apr 5.

PMID:
28527578
6.

The caterpillar fungus, Ophiocordyceps sinensis, genome provides insights into highland adaptation of fungal pathogenicity.

Xia EH, Yang DR, Jiang JJ, Zhang QJ, Liu Y, Liu YL, Zhang Y, Zhang HB, Shi C, Tong Y, Kim C, Chen H, Peng YQ, Yu Y, Zhang W, Eichler EE, Gao LZ.

Sci Rep. 2017 May 11;7(1):1806. doi: 10.1038/s41598-017-01869-z.

7.

SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.

Mao LJ, Yang CH, Fan L, Gao P, Yang DR, Xue BX, Zheng JN, Shan YX.

Biomed Pharmacother. 2016 Apr;79:1-8. doi: 10.1016/j.biopha.2016.01.038. Epub 2016 Feb 9.

PMID:
27044805
8.

Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials.

Zang YC, Deng XX, Yang DR, Xue BX, Xu LJ, Liu XL, Zhou YB, Shan YX.

Lasers Med Sci. 2016 Feb;31(2):235-40. doi: 10.1007/s10103-015-1843-1. Epub 2015 Dec 28. Review.

PMID:
26712715
9.

In vivo determination of muscle-derived stem cells in rat corpus cavernosum.

Xu LJ, Xue BX, Shan YX, Chen D, Gao J, Yang DR, Sun CY, Cui Y.

Genet Mol Res. 2015 Aug 21;14(3):9951-62. doi: 10.4238/2015.August.21.1.

10.

Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.

Mao LJ, Zhang J, Liu N, Fan L, Yang DR, Xue BX, Shan YX, Zheng JN.

Tumour Biol. 2015 Nov;36(11):9073-81. doi: 10.1007/s13277-015-3658-x. Epub 2015 Jun 19.

PMID:
26084613
11.

TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.

Lin SJ, Yang DR, Li G, Chang C.

Front Endocrinol (Lausanne). 2015 May 27;6:78. doi: 10.3389/fendo.2015.00078. eCollection 2015. Review.

12.

TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.

Qiu X, Zhu J, Sun Y, Fan K, Yang DR, Li G, Yang G, Chang C.

Oncotarget. 2015 Jun 20;6(17):15397-409.

13.

Electrically pumped random lasing with an onset voltage of sub-3 V from ZnO-based light-emitting devices featuring nanometer-thick MoO3 interlayers.

Wang CX, Lv CY, Zhu C, Gao ZF, Li DS, Ma XY, Yang DR.

Nanoscale. 2015 May 28;7(20):9164-8. doi: 10.1039/c5nr01562f.

PMID:
25939680
14.

The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.

Lin SJ, Lin CY, Yang DR, Izumi K, Yan E, Niu X, Chang HC, Miyamoto H, Wang N, Li G, Chang C.

Neoplasia. 2015 Apr;17(4):339-47. doi: 10.1016/j.neo.2015.02.005.

15.

TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.

Lin SJ, Yang DR, Wang N, Jiang M, Miyamoto H, Li G, Chang C.

Oncoscience. 2015 Feb 9;2(2):142-50. eCollection 2015.

16.

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

Yang DR, Zhu HZ.

World J Gastroenterol. 2015 Apr 7;21(13):3786-800. doi: 10.3748/wjg.v21.i13.3786. Review.

17.

TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.

Zhu J, Yang DR, Sun Y, Qiu X, Chang HC, Li G, Shan Y, Chang C.

Mol Cancer Ther. 2015 Jun;14(6):1445-53. doi: 10.1158/1535-7163.MCT-14-0971. Epub 2015 Apr 1.

18.

New records of ant species from Yunnan, China.

Liu C, Guénard B, Garcia FH, Yamane S, Blanchard B, Yang DR, Economo E.

Zookeys. 2015 Jan 26;(477):17-78. doi: 10.3897/zookeys.477.8775. eCollection 2015.

19.

Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.

Ding X, Yang DR, Xia L, Chen B, Yu S, Niu Y, Wang M, Li G, Chang C.

Mol Cancer. 2015 Jan 27;14:16. doi: 10.1186/s12943-014-0281-1.

20.

The incidence and pattern of copollinator diversification in dioecious and monoecious figs.

Yang LY, Machado CA, Dang XD, Peng YQ, Yang DR, Zhang DY, Liao WJ.

Evolution. 2015 Feb;69(2):294-304. doi: 10.1111/evo.12584. Epub 2015 Jan 19.

Supplemental Content

Support Center